AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 25154757 — intervention group
Group type: COMPARATOR
Intervention: Acetaminophen (500 mg, three times a day for 72 hr)
Number of subjects: 29
Study 24107481 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel 40 mg/m² and cisplatin 40 mg/m² biweekly on days 1 and 15 every 4 weeks
Number of subjects: 48
Study 21375777 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose AmBisome® (7.5 mg/kg, escalating to 10, 12.5, and 15 mg/kg if ineffective)
Number of subjects: 120
Study 21375777 — intervention group
Group type: COMPARATOR
Intervention: Multi-dose AmBisome® (3 mg/kg/day on days 1-5, 14, and 21; total dose 21 mg/kg)
Number of subjects: 120
Study 21375777 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose AmBisome®
Number of subjects: 120
Study 21375777 — intervention group
Group type: COMPARATOR
Intervention: Multi-dose AmBisome®
Number of subjects: 120
Study 19533313 — intervention group
Group type: EXPERIMENTAL
Intervention: Active allergen immunotherapy (IT) with single insect extract (cockroach, housefly, or mosquito) and mixed allergen IT (two or three insect extracts)
Number of subjects: 99
Study 19533313 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study 18603898 — intervention group
Group type: EXPERIMENTAL
Intervention: Misgav Ladach technique
Number of subjects: 400
Study 18603898 — intervention group
Group type: COMPARATOR
Intervention: Conventional method
Number of subjects: 400
Study 14514933 — intervention group
Group type: EXPERIMENTAL
Intervention: Bradykinin (BK)
Number of subjects: 10
Study 14514933 — intervention group
Group type: COMPARATOR
Intervention: L‐NMMA
Number of subjects: 10
Study 10648310 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ketamine/midazolam
Number of subjects: 51
Study 10648310 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular meperidine, promethazine, and chlorpromazine (DPT)
Number of subjects: 51
Study 8862501 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine (BRC, 2.5 mg po)
Number of subjects: 6
Study 8862501 — intervention group
Group type: COMPARATOR
Intervention: Arginine (ARG, 0.5 g/Kg iv in 30 min)
Number of subjects: 6
Study 1738963 — intervention group
Group type: EXPERIMENTAL
Intervention: One-dose regimen of cefuroxime
Number of subjects: 2651
Study 1738963 — intervention group
Group type: COMPARATOR
Intervention: Three-dose regimen of cefuroxime
Number of subjects: 2651
Study 6469757 — intervention group
Group type: EXPERIMENTAL
Intervention: Misonidazole treatment
Number of subjects: 0
Study 30487126 — intervention group
Group type: EXPERIMENTAL
Intervention: Panitumumab
Number of subjects: 261
Study 29587324 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab (Opdivo®)
Number of subjects: 0
Study 29587324 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab + Ipilimumab
Number of subjects: 0
Study 29587324 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab + Bevacizumab
Number of subjects: 0
Study 29587324 — intervention group
Group type: COMPARATOR
Intervention: Sunitinib
Number of subjects: 0
Study 27505315 — intervention group
Group type: EXPERIMENTAL
Intervention: Wavefront-guided PRK
Number of subjects: 68
Study 27505315 — intervention group
Group type: COMPARATOR
Intervention: Wavefront-optimized PRK
Number of subjects: 68
Study 24760847 — intervention group
Group type: EXPERIMENTAL
Intervention: BDNF Met(66) carriers
Number of subjects: 72
Study 24760847 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo administration
Number of subjects: 72
Study 24760847 — intervention group
Group type: EXPERIMENTAL
Intervention: Monetary gains
Number of subjects: 72
Study 22149876 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus plus exemestane
Number of subjects: 724
Study 22149876 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus exemestane
Number of subjects: 724
Study 20551634 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravaginal pentamycin 3, 10, 30, 60 or 100 mg
Number of subjects: 31
Study 20551634 — intervention group
Group type: COMPARATOR
Intervention: Pentamycin vehicle
Number of subjects: 31
Study 20551634 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravaginal pentamycin 60 mg
Number of subjects: 31
Study 20551634 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravaginal pentamycin 100 mg
Number of subjects: 31
Study 17402934 — intervention group
Group type: EXPERIMENTAL
Intervention: Human Patient Simulators (HPS) in addition to usual clinical training
Number of subjects: 12
Study 17402934 — intervention group
Group type: COMPARATOR
Intervention: Usual clinical training alone
Number of subjects: 12
Study 15630048 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan cilexitil
Number of subjects: 0
Study 15630048 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 12394817 — intervention group
Group type: EXPERIMENTAL
Intervention: PnCV reconstituted in TETRAMUNE as a single injection in the right thigh (combined)
Number of subjects: 0
Study 12394817 — intervention group
Group type: EXPERIMENTAL
Intervention: PnCV in the left thigh and TETRAMUNE in the right thigh (separate)
Number of subjects: 0
Study 12394817 — intervention group
Group type: COMPARATOR
Intervention: Placebo reconstituted in TETRAMUNE in the right thigh (control)
Number of subjects: 0
Study 12394817 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined group (PnCV reconstituted in TETRAMUNE)
Number of subjects: 0
Study 12394817 — intervention group
Group type: EXPERIMENTAL
Intervention: Separate group (PnCV and TETRAMUNE separately)
Number of subjects: 0
Study 12394817 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 0
Study 10438983 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh blastocysts (cocultured or cultured in sequential media)
Number of subjects: 0
Study 10438983 — intervention group
Group type: COMPARATOR
Intervention: Spontaneous conception
Number of subjects: 0
Study 7763203 — intervention group
Group type: EXPERIMENTAL
Intervention: Selegiline hydrochloride (L-deprenyl)
Number of subjects: 800
Study 7763203 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E (alpha-tocopherol)
Number of subjects: 800
Study 7763203 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 800
Study 2272092 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 40 mg
Number of subjects: 27
Study 2272092 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 86677 — intervention group
Group type: EXPERIMENTAL
Intervention: Infants discharged when clinically well and after passing the nadir of postnatal weight-loss.
Number of subjects: 40
Study 86677 — intervention group
Group type: COMPARATOR
Intervention: Infants discharged at a traditional weight of 2200 g.
Number of subjects: 40
Study 31595499 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab 2 mg kg‐1
Number of subjects: 40
Study 31595499 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab 4 mg kg‐1
Number of subjects: 40
Study 31595499 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab (both doses)
Number of subjects: 40
Study 30292541 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciliary neurotrophic factor (CNTF) treatment
Number of subjects: 67
Study 30292541 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 67
Study 27765690 — intervention group
Group type: EXPERIMENTAL
Intervention: Animal Protein Diet (AP); rich in meat and dairy foods
Number of subjects: 37
Study 27765690 — intervention group
Group type: EXPERIMENTAL
Intervention: Plant Protein Diet (PP); mainly legume protein
Number of subjects: 37
Study 25800457 — intervention group
Group type: EXPERIMENTAL
Intervention: Paliperidone palmitate once‐monthly injectable antipsychotic (PP1M)
Number of subjects: 0
Study 25800457 — intervention group
Group type: EXPERIMENTAL
Intervention: Paliperidone palmitate monotherapy (PP1M)
Number of subjects: 0
Study 25800457 — intervention group
Group type: EXPERIMENTAL
Intervention: Paliperidone palmitate adjunctive therapy (PP1M)
Number of subjects: 0
Study 25800457 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 22889586 — intervention group
Group type: EXPERIMENTAL
Intervention: 24IU intranasal oxytocin
Number of subjects: 17
Study 22889586 — intervention group
Group type: EXPERIMENTAL
Intervention: 48IU intranasal oxytocin
Number of subjects: 17
Study 22889586 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 20657311 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise 1 (E1: 20 minutes, 1 lap in the circuit)
Number of subjects: 16
Study 20657311 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise 2 (E2: 40 minutes, 2 laps in the circuit)
Number of subjects: 16
Study 20657311 — intervention group
Group type: COMPARATOR
Intervention: Control (C: 40 minutes of rest)
Number of subjects: 16
Study 19448386 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition and exercise strategies
Number of subjects: 62
Study 19448386 — intervention group
Group type: COMPARATOR
Intervention: Staff compliance
Number of subjects: 62
Study 16733169 — intervention group
Group type: EXPERIMENTAL
Intervention: Cell-saver processed suction blood (n = 13)
Number of subjects: 25
Study 16733169 — intervention group
Group type: COMPARATOR
Intervention: Cell-saver unprocessed suction blood (n = 12)
Number of subjects: 25
Study 16733169 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation with tumor necrosis factor alpha concentration
Number of subjects: 25
Study 11901581 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 gauge mini brackets
Number of subjects: 80
Study 11901581 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 gauge standard brackets
Number of subjects: 80
Study 11901581 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 gauge mini brackets
Number of subjects: 80
Study 11901581 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 gauge standard brackets
Number of subjects: 80
Study 11901581 — intervention group
Group type: COMPARATOR
Intervention: Comparison between 80 and 100 gauge mini and standard size brackets
Number of subjects: 80
Study 11901581 — intervention group
Group type: COMPARATOR
Intervention: Brackets of the same surface area with different gauge mesh size
Number of subjects: 80
Study 10421835 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled beclomethasone dipropionate (BDP)
Number of subjects: 98
Study 10421835 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 98
Study 7495111 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride 5 mg once daily
Number of subjects: 707
Study 7495111 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 707
Study 2268518 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin ethylsuccinate tablets at a dose of 1 g twice daily
Number of subjects: 619
Study 2268518 — intervention group
Group type: COMPARATOR
Intervention: Ciprofloxacin tablets 500 mg twice daily
Number of subjects: 619
Study 298342 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg naloxone
Number of subjects: 26
Study 298342 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg naloxone
Number of subjects: 26
Study 298342 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 31809418 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiographic Union Score for Hip (RUSH) at 3 months
Number of subjects: 734
Study 31809418 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiographic Union Score for Hip (RUSH) at 6 months
Number of subjects: 734
Study 29530262 — intervention group
Group type: EXPERIMENTAL
Intervention: Cool Little Kids Online program (CBT-based, eight modules)
Number of subjects: 433
Study 29530262 — intervention group
Group type: COMPARATOR
Intervention: Wait-list group (control)
Number of subjects: 433
Study 26927445 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium-glucose co-transporter-2 inhibitors
Number of subjects: 28
Study 26927445 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 26155597 — intervention group
Group type: EXPERIMENTAL
Intervention: DMPA
Number of subjects: 3141
Study 26155597 — intervention group
Group type: COMPARATOR
Intervention: NET-EN
Number of subjects: 3141
Study 26155597 — intervention group
Group type: EXPERIMENTAL
Intervention: DMPA (among HSV-2 seropositive women)
Number of subjects: 3141
Study 26155597 — intervention group
Group type: COMPARATOR
Intervention: NET-EN (among HSV-2 seronegative women)
Number of subjects: 3141
Study 23102798 — intervention group
Group type: EXPERIMENTAL
Intervention: EE 30 mcg/CMA 2 mg
Number of subjects: 64
Study 23102798 — intervention group
Group type: EXPERIMENTAL
Intervention: EE 30 mcg/LNG 150 mcg
Number of subjects: 64
Study 23102798 — intervention group
Group type: COMPARATOR
Intervention: Control (nonhormonal contraceptive method)
Number of subjects: 64
Study 20576732 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol/fluticasone propionate 50/500 μg bid (SFC)
Number of subjects: 1323
Study 20576732 — intervention group
Group type: COMPARATOR
Intervention: Tiotropium 18 μg once daily (Tio)
Number of subjects: 1323
Study 20576732 — intervention group
Group type: EXPERIMENTAL
Intervention: SFC
Number of subjects: 1323
Study 20576732 — intervention group
Group type: COMPARATOR
Intervention: Tio
Number of subjects: 1323
Study 18349781 — intervention group
Group type: EXPERIMENTAL
Intervention: New external fixation components
Number of subjects: 96
Study 18349781 — intervention group
Group type: COMPARATOR
Intervention: Refurbished external fixation components
Number of subjects: 96
Study 16814402 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial tonsil resection/tonsillotomy (TT)
Number of subjects: 92
Study 16814402 — intervention group
Group type: COMPARATOR
Intervention: Full tonsillectomy (TE)
Number of subjects: 92
Study 16814402 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain relievers (opioids, paracetamol, diclofenac)
Number of subjects: 92
Study 12488379 — intervention group
Group type: EXPERIMENTAL
Intervention: i.v. PCA morphine (dose, 1 mg; lockout interval, 8 min)
Number of subjects: 40
Study 12488379 — intervention group
Group type: COMPARATOR
Intervention: Regular s.c. morphine injections
Number of subjects: 40
Study 10466476 — intervention group
Group type: EXPERIMENTAL
Intervention: High salt (NaCl = 240 mmol/day)
Number of subjects: 31
Study 10466476 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin (25 mg three times daily)
Number of subjects: 31
Study 10466476 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic high NaCl and Indomethacin
Number of subjects: 31
Study 10466476 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic high NaCl
Number of subjects: 31
Study 10466476 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 31
Study 10466476 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic high NaCl in ISH group
Number of subjects: 31
Study 10466476 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin in normotensive individuals
Number of subjects: 31
Study 8706194 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual triazolam 0.2 mg (T)
Number of subjects: 81
Study 8706194 — intervention group
Group type: COMPARATOR
Intervention: Peroral diazepam 10 mg (D)
Number of subjects: 81
Study 2082487 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyridamole 100 mg q.i.d. starting 2 days before surgery, followed by aspirin 325 mg t.i.d. plus dipyridamole 75 mg t.i.d. 7 hours after surgery
Number of subjects: 0
Study 2082487 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiplatelet regimen (dipyridamole and aspirin)
Number of subjects: 0
Study 346168 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% adenine arabinoside (Ara‐A) in petrolatum ointment base applied four times daily for one week
Number of subjects: 22
Study 346168 — intervention group
Group type: COMPARATOR
Intervention: Base alone applied four times daily for one week
Number of subjects: 22
Study 31610811 — intervention group
Group type: EXPERIMENTAL
Intervention: Intention to leave
Number of subjects: 336
Study 31610811 — intervention group
Group type: EXPERIMENTAL
Intervention: Dissatisfaction with educational opportunities
Number of subjects: 336
Study 31610811 — intervention group
Group type: EXPERIMENTAL
Intervention: Poor pays and benefits
Number of subjects: 336
Study 31610811 — intervention group
Group type: EXPERIMENTAL
Intervention: Lack of recognition
Number of subjects: 336
Study 31610811 — intervention group
Group type: EXPERIMENTAL
Intervention: Poor working environments
Number of subjects: 336
Study 31610811 — intervention group
Group type: EXPERIMENTAL
Intervention: High workload
Number of subjects: 336
Study 31610811 — intervention group
Group type: EXPERIMENTAL
Intervention: Low affective commitment
Number of subjects: 336
Study 31610811 — intervention group
Group type: EXPERIMENTAL
Intervention: Being unmarried
Number of subjects: 336
Study 27838323 — intervention group
Group type: EXPERIMENTAL
Intervention: Grass SLIT-tablet (MK-7243; ≤2800 bioequivalent allergen units/75,000 SQ-T dose)
Number of subjects: 2497
Study 27838323 — intervention group
Group type: EXPERIMENTAL
Intervention: Short ragweed SLIT-tablet (MK-3641; ≤12 Amb a 1-U)
Number of subjects: 2497
Study 27838323 — intervention group
Group type: EXPERIMENTAL
Intervention: House dust mite SLIT-tablet (MK-8237; ≤12 SQ-HDM)
Number of subjects: 2497
Study 27838323 — intervention group
Group type: COMPARATOR
Intervention: Placebo (for all SLIT-tablet trials)
Number of subjects: 2497
Study 26692201 — intervention group
Group type: EXPERIMENTAL
Intervention: Antenatal magnesium sulfate (BEAM trial)
Number of subjects: 289
Study 25086152 — intervention group
Group type: EXPERIMENTAL
Intervention: SmartConsent (personalized informed consent generated through EHR)
Number of subjects: 50
Study 25086152 — intervention group
Group type: COMPARATOR
Intervention: Standard consent (control group)
Number of subjects: 50
Study 22071367 — intervention group
Group type: EXPERIMENTAL
Intervention: Low intensity pain
Number of subjects: 60
Study 22071367 — intervention group
Group type: EXPERIMENTAL
Intervention: High intensity pain
Number of subjects: 60
Study 19259813 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 cm H(2)O of positive end-expiratory pressure maintained until extubation (Group I)
Number of subjects: 32
Study 19259813 — intervention group
Group type: COMPARATOR
Intervention: Positive end-expiratory pressure (PEEP) of 5 cm H(2)O increased to 14 cm H(2)O every 20 min for 2 min during cross clamp (Group II)
Number of subjects: 32
Study 17763840 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 x 10 min sessions per day (n = 9)
Number of subjects: 18
Study 17763840 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 x 30 min session per day (n = 9)
Number of subjects: 18
Study 17763840 — intervention group
Group type: COMPARATOR
Intervention: Matched time-control group (n = 10)
Number of subjects: 18
Study 16283847 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional laparoscopic instruments
Number of subjects: 20
Study 16283847 — intervention group
Group type: EXPERIMENTAL
Intervention: daVinci Robotic System
Number of subjects: 20
Study 16283847 — intervention group
Group type: COMPARATOR
Intervention: Robotics
Number of subjects: 20
Study 12027488 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyapatite cement
Number of subjects: 18
Study 12027488 — intervention group
Group type: COMPARATOR
Intervention: Kapandji wiring
Number of subjects: 18
Study 9807337 — intervention group
Group type: EXPERIMENTAL
Intervention: Geriatric nursing education workshop
Number of subjects: 43
Study 8689980 — intervention group
Group type: EXPERIMENTAL
Intervention: Halofantrine
Number of subjects: 335
Study 8689980 — intervention group
Group type: COMPARATOR
Intervention: Metakelfin
Number of subjects: 335
Study 31613323 — intervention group
Group type: EXPERIMENTAL
Intervention: Ongoing anticholinergic medication
Number of subjects: 510
Study 30120283 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 minutes of acute exergaming (physical activity of moderate intensity)
Number of subjects: 46
Study 30120283 — intervention group
Group type: COMPARATOR
Intervention: Control condition (sedentary)
Number of subjects: 46
Study 27452270 — intervention group
Group type: EXPERIMENTAL
Intervention: OFD + PRF + 1.2% RSV gel
Number of subjects: 90
Study 27452270 — intervention group
Group type: EXPERIMENTAL
Intervention: OFD + PRF
Number of subjects: 90
Study 27452270 — intervention group
Group type: COMPARATOR
Intervention: OFD alone
Number of subjects: 90
Study 25681432 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised endurance exercise (14 wk, 3-4 days/wk, 120-240 min/wk, 65-85% of maximum heart rate)
Number of subjects: 58
Study 25681432 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 58
Study 23113643 — intervention group
Group type: EXPERIMENTAL
Intervention: fermented bilberry extract (400 mg/day)
Number of subjects: 30
Study 23113643 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 30
Study 21436726 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 (2×10(11) CFU/d)
Number of subjects: 60
Study 21436726 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 19427372 — intervention group
Group type: EXPERIMENTAL
Intervention: GSM 890 MHz signal exposure for 30 minutes
Number of subjects: 41
Study 16398734 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 percent human albumin plus Ringer's lactate
Number of subjects: 42
Study 16398734 — intervention group
Group type: COMPARATOR
Intervention: Ringer's lactate
Number of subjects: 42
Study 15276691 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 77
Study 15276691 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 77
Study 15276691 — intervention group
Group type: EXPERIMENTAL
Intervention: Perospirone
Number of subjects: 77
Study 15276691 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 77
Study 11418283 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 105
Study 11418283 — intervention group
Group type: EXPERIMENTAL
Intervention: Maprotiline
Number of subjects: 105
Study 9249109 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural fentanyl infusion (Group III)
Number of subjects: 50
Study 9249109 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous fentanyl (Group II)
Number of subjects: 50
Study 9249109 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Group I)
Number of subjects: 50
Study 8493215 — intervention group
Group type: EXPERIMENTAL
Intervention: GM-CSF (E. coli) 250 micrograms/m2/day
Number of subjects: 91
Study 8493215 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91